In this week’s Healthcare Preview, Rodney Whitlock and Debbie Curtis join Erin Fuller to discuss both chambers’ return from recess and what to watch for this week, including potential House healthcare markups, Senate HELP Committee nomination hearings, and more. 🎙️ Listen: https://lnkd.in/eqty4z8C Read more of the #healthpolicy issues shaping the week ahead: https://lnkd.in/eVrbgkWV
McDermott+
Business Consulting and Services
Washington, District of Columbia 3,431 followers
Sound Health Policy Objectives, Achieved.
About us
McDermott+ serves health industry clients with one-stop lobbying services, data analytics and modeling and policy advice. When clients are faced with legislative and regulatory obstacles that challenge business operations and opportunities, they turn to us for solutions. In providing these services, M+ has access to the resources and talent of McDermott Will & Schulte LLP, including its most accomplished and renowned health law practice. M+ uses analytics to frame and scope issues and challenges, identifies policy alternatives, and develops and implements lobbying strategies to advance business solutions including: + Legislative and Executive Branch lobbying strategy and execution + Budget impact and cost-effectiveness models + Political communications strategy + Public and private payor coverage, coding and pricing strategy and implementation + Code application strategy, pursuit and support services + Health financing data analysis and modeling to evaluate transactions and litigation We are seasoned professionals with extensive experience working in Congress, administrative agencies and industry. Our integrated team includes consultants with clinical backgrounds, and all of us work exclusively in the health industry. M+ is a wholly-owned subsidiary of McDermott Will & Schulte LLP.
- Website
-
https://www.mcdermottplus.com/
External link for McDermott+
- Industry
- Business Consulting and Services
- Company size
- 11-50 employees
- Headquarters
- Washington, District of Columbia
- Type
- Privately Held
- Founded
- 2014
- Specialties
- Lobbying Services, Data Analytics and Modeling, and Policy Advice
Locations
-
Primary
Get directions
500 N Capitol St NW
Washington, District of Columbia 20001, US
Employees at McDermott+
Updates
-
Catch up on the #healthpolicy news of the week: >CMS releases CY 2027 OPPS and ASC Payment System proposed rule >HHS, CMS launch “Make Hospital Food Healthier” pledge >House Ways and Means Committee advances hospital reporting legislation >House Education and Workforce Health Subcommittee discusses direct contracting in healthcare 👉https://lnkd.in/gyufrMEP Authors: Debbie Curtis | Kristen O'Brien | Erica Stocker | Madalyn News | Erin Fuller
-
-
As Medicare Advantage and Part D continue to evolve, healthcare stakeholders need to understand how changes in policy, payment, and program oversight may affect access, utilization, reimbursement, and long-term planning. McDermott+ now has access to expanded Medicare data assets that can help inform policy and business planning. Learn more: https://lnkd.in/eArHZUcH
-
-
In this week’s Regs & Eggs, Jeffrey Davis, Deborah Godes, Marla Kugel, and Devin Stone break down CMS’s CY 2027 OPPS proposed rule and explain how data analysis can help healthcare stakeholders understand projected payment impacts and key policy changes. 👉https://lnkd.in/g5rfym8g
-
-
CMS recently released the CY 2027 OPPS/ASC Payment System proposed rule, featuring updates to payment rates, the next phase of IPO list removals, expanded ASC-covered procedures, site-neutral payment changes, 340B policies, and new approaches to software as a medical service. Read key takeaways from the proposed rule and access our interactive dashboard: https://lnkd.in/eA8ki7MV Authors: Deborah Godes | Jeffrey Davis | Marie Knoll | Marla Kugel | Anthony Livshen | Lynn Nonnemaker | Devin Stone | Katie Weider Waldo | Eric Zimmerman
-
-
In this week’s Healthcare Preview, Debbie Curtis and Rodney Whitlock join Madalyn News to discuss what’s been heating up in Congress over the last few months and what’s on the horizon for the rest of the year. 🎙️ Listen: https://lnkd.in/d4ieYG_x Read more of the #healthpolicy issues shaping the week ahead: https://lnkd.in/dAR_kC_J
-
-
Catch up on the #healthpolicy news of the week: >State Medicaid directors testify before House Energy and Commerce Oversight Subcommittee >House Energy and Commerce Health Subcommittee advances 15 health bills >Federal judge temporarily blocks Department of Education definition of “professional degree” in student loan final rule 👉https://lnkd.in/gHakzGRP Authors: Debbie Curtis | Kristen O'Brien | Erica Stocker | Madalyn News | Erin Fuller
-
-
Medicare payment changes aren’t always final. Sometimes, the right data can change the outcome. When CMS proposed a 5% reduction in Medicare reimbursement for cataract surgery, our team dug into the data to understand what was driving the change. The analysis uncovered an error in CMS’s methodology, helping turn a proposed 5% cut into a final 4% increase. Behind every successful advocacy strategy is a deep understanding of the data. Read the full case study here: https://lnkd.in/g9xNtDHs Authors: Marla Kugel | Devin Stone
-
This week in the Breakroom, Amy Kelbick joins Madalyn News to discuss recent federal drug pricing developments, including key requests for information, proposed rules, and what stakeholders should be watching this summer. 🎙️Listen: https://lnkd.in/gCy6fu5v
-
-
In this week’s Regs & Eggs, Jeffrey Davis, Amy Kelbick, and Lynn Nonnemaker examine CMS’ latest prescription drug pricing actions and the potential implications for healthcare stakeholders. 👉https://lnkd.in/edZVPVYp
-